The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
NCT ID: NCT06477497
Last Updated: 2024-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
33 participants
OBSERVATIONAL
2024-07-01
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To explore the feasibility and universality of the bundled prevention and treatment strategy for placenta accreta spectrum disorders in different levels of medical institutions, and to investigate its effectiveness in improving the specialized disease management capabilities of medical institutions at all levels. We will conduct a regional, cluster-randomized trial to assess a multicomponent PAS management strategy to improve the prepartum detection rate of PAS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI for the Diagnosis of Placenta Accreta Spectrum
NCT04151979
Observation of Strategies in Placenta Accreta Spectrum Management
NCT07236710
Evaluation of Planned Conservative Surgical Management of Placenta Accreta Spectrum in Women's Health Center, Assiut University Hospital
NCT06712576
Prospective Cohort Observational Study of Placenta Accreta Spectrum Disorders
NCT06021964
Risk Factors, Prognosis and Prediction Models for Placenta Accreta Without Prior Cesarean Section
NCT06383923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Theoretical training, technical supporting and standardized referral process
No interventions assigned to this group
control group
usual care
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant women diagnosed with PAS before or after delivery
Exclusion Criteria
* Pregnant women who were lost to follow-up during the study period
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Key Research and Development Program of China
UNKNOWN
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022YFC2704505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.